Skip to content
MS
Sign in
Single-pathway Pathway metabolite unreviewed

Dihydroceramide

0
Pathways
0
Categories
0
As substrate
0
As product
What can this become? Show on map

Reactions involving Dihydroceramide

Every recorded step where this molecule takes part

All 2 Consumed 1 Produced 1

Showing all 2 reactions.

Recent literature

Refresh

Europe PMC · from cache · sorted by publication date

  1. 1
    Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib.

    Huang F, Zhan P, Shi X, Sun Y, Song X, Sun P, Liu B. · 2026-05-22

    open access unreviewed
  2. 2
    Metabolomic profiling of neat uterine luminal fluid in cows: local enrichment and nutritional modulation.

    Sagheer M, Hoorn QA, Maldonado MB, Schalich KM, Ashrafi N, A Mimi R, Graham SF, Selvaraj V, Hansen PJ. · 2026-01-07

    cited 3× open access unreviewed
  3. 3
    Sphingolipid metabolism meets natural bioactives: A new perspective on metabolic disease intervention.

    He Y, Tan J, Liu J, Zhong R, Jiang L, Zhao Y. · 2026-06-10

    unreviewed
  4. 4
    Sphingolipid homeostasis and dysregulation in liver function and disease.

    Lan J, Pan Z, Dong W, Wang J, Zhang C, Zhang Y, Wu Y, Jin J. · 2026-04-24

    open access unreviewed
  5. 5
    The Liver as the Central Regulator of Cholesterol Homeostasis: Statins, Gut Microbiota, Hepatic Inflammation, and the Proposed Oral-Gut-Liver-Artery Axis in Atherogenesis.

    Cannon M, Peldyak J, Campbell E. · 2026-07-13

    unreviewed
  6. 6
    Localization of Ceramide Synthase 5 in Mouse Retina.

    Song SJ, Koo JH, Kim HY, Park JW, Paik SS, Kim IB, Shin JA. · 2026-07-01

    unreviewed
  7. 7
    Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular Carcinoma.

    Safri F, Pickford R, Xu Y, Yang W, Nguyen R, Yuen L, Lam V, Nahm C, Pang T, George J, Qiao L. · 2026-07-06

    unreviewed
  8. 8
    ORMDL3 as Key Regulator of Endothelial Dysfunction in Atherosclerosis via Sphingolipid Biosynthesis.

    Wang L, Yun Y, Song Y, Zhao D, Li J, Zhang S, Wang Z, Ma X. · 2026-07-02

    unreviewed
  9. 9
    Effects and mechanisms of lipidomic and development alterations in ire-1 mutant Caenorhabditis elegans under extremely low-frequency electromagnetic field exposure.

    Sun Y, Yan W, Guo Y, Jia X, Zhang Z. · 2026-06-17

    unreviewed
  10. 10
    Low concentrations of sorafenib increase dihydrosphingomyelin during antifibrotic processes in human hepatic stellate cells.

    Kim Y, Ham B, Kim Y, Jung BH, Park J, Lee H. · 2026-04-29

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.